Paper
Matching-adjusted indirect comparison of enzalutamide versus apalutamide with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer
Future Oncology · 2026 · Arun A Azad, Bhavik J Pandya, Hemant Singh Bhadauria et al.